Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Q4 2024 Healthcare Services Group Inc Earnings Call

In This Article:

Participants

Theodore Wahl; President, Chief Executive Officer, Director; Healthcare Services Group Inc

Matthew McKee; Chief Communications Officer; Healthcare Services Group Inc

Vikas Singh; Chief Financial Officer; Healthcare Services Group Inc

Sean Dodge; Analyst; RBC Capital Markets

Andy Wittmann; Analyst; Robert W. Baird & Co. Incorporated

AJ Rice; Analyst; UBS

Jack Senft; Analyst; William Blair & Company

Presentation

Operator

Good day. The matters discussed on today's conference call include forward-looking statements about the business prospects of Healthcare Services Group, Inc. For Healthcare Services Group, Inc.'s most recent forward-looking statements, please refer to the press release issued this morning, which can be found on our website at www.hcsg.com.
Actual results may differ materially from those expressed or implied as a result of various risks, uncertainties, and important factors, including those discussed in the Risk Factors, MD&A, and other sections of the annual report on Form 10-K and Healthcare Services Group, Inc.'s other SEC filings, and as indicated in our most recent forward-looking statement notice.
Additionally, management will be discussing certain non-GAAP financial measures. A reconciliation of these items to US GAAP can be found in this morning's press release. I'd now like to hand it over to Ted Wahl, CEO. You may now begin.

Theodore Wahl

Good morning, everyone, and welcome to HCSG's fourth-quarter 2024 earnings call. With me today are Matt McKee, our Chief Communications Officer; and Vikas Singh, our Chief Financial Officer. Earlier this morning, we released our fourth-quarter results and plan on filing our 10-K by the end of the week.
Today, in my opening remarks, I'll discuss our Q4 highlights, share our perspective on the latest industry trends and developments, and discuss our 2025 outlook. Matt will then provide a more detailed discussion on our Q4 results. And then Vikas will provide an update on our liquidity position and share our 2025 capital allocation priorities. We will then open up the call for Q&A. So with that overview, I'd like to now discuss our Q4 highlights.
2024 was a transitional year for HCSG, as it marked a pivotal shift from recovery to renewed growth. This shift was highlighted by our Q4 results and the positive momentum we're carrying into the new year. For the three months ended December 31, we reported revenue of $437.8 million; net income and diluted EPS of $11.9 million and $0.16, inclusive of new business start-up costs; and reported cash flow from operations of $36.2 million; and actual cash flow from operations, excluding the change in payroll accrual of $27 million.
I'd like to now share our perspective on the latest industry trends and developments. Industry fundamentals continue to gain strength, highlighted by the powerful multi-decade demographic tailwind that is now beginning to work its way into the long-term and post-acute care system.
In 2026, the first baby boomers will turn 80 years old. And by the year 2030, all 70 million-plus boomers will be over the age of 65, with the oldest being in their mid-80s, the primary age cohort for long-term and post-acute care utilization.
We expect that the demand and opportunities for service providers in this space, especially for those with compelling value propositions, durable business models, and market-leading positions to only increase in the months and years ahead.
The industry's most recent operating trends remain positive as well, highlighted by a steady increase in workforce availability, with the industry adding over 100,000 jobs since the beginning of 2023; rising occupancy, which now sits at 80%, in line with pre-pandemic levels; and a stable reimbursement environment, which includes October's 4.2% increase in Medicare rates for fiscal year 2025; as well as continued positive reimbursement trends at the state level.
On the regulatory front, we continue to believe that CMS' final minimum staffing rule will either undergo significant revision during the extended phase-in period or be eliminated in its entirety, especially given the pending litigation and recent change in administration. Regarding the change in administration, we believe that President Trump's pro-business priorities on taxes, energy, and regulation will be a net benefit to most US domestics, including ours.
Specifically to the industry, the Trump administration was very collaborative and supportive of the provider community during the first term. And while it's still too early to know exactly what, if any, reimbursement, regulatory, or administrative changes will be pursued, overall industry sentiment on the new administration remains positive.
As far as the outlook for 2025, our top three strategic priorities continue to be as follows. Our first priority is driving growth by executing on our organic growth strategy through hiring, training, and developing future management candidates; converting opportunities from our sales pipeline into new business adds; and retaining our existing facility business. We expect mid-single-digit revenue growth in the year ahead and estimate a Q1 revenue range of $440 million to $450 million.
Our second priority is managing costs, managing cost of services in line with our target of 86% and managing SG&A into the targeted range of 8.5% to 9.5%. Our key operating trends for customer experience, system adherence, regulatory compliance, and budget discipline continued to trend positively throughout 2024.
And our field-based team remains laser-focused on exceeding expectations in the year ahead. This operational execution, coupled with prudent spend management at the enterprise level, positions us very well to deliver on this priority in 2025.
Our third priority is optimizing cash flow. Our cash flow continued to gain strength throughout 2024, culminating in an outstanding fourth quarter, largely fueled by our strongest cash collection results in over three years. We estimate 2025 actual cash flow from operations, excluding the change in payroll accrual in the range of $45 million to $60 million.
Looking ahead, we are confident that focusing on our strategic priorities, supported by our strong business fundamentals, will enable us to further accelerate growth, enhance profitability, and maximize cash flow through 2025 and beyond.
So with those opening comments, I'll turn the call over to Matt for a more detailed discussion on the quarter.


Waiting for permission
Allow microphone access to enable voice search

Try again.